Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by thediggeron Dec 21, 2018 10:51am

96 Views

Post# 29146087

RE:Proof in the pudding

My god buddy, what are you trying to achieve. Read carefully:

https://www.stockhouse.com/news/press-releases/2018/09/26/new-age-farm-signs-definitive-agreement-to-acquire-cbd-beverage-company-fresh

"DFW was established in California by a group of industry leaders. Their flagship product, a CBD infused, nano amplified alkaline water has continued to grow steadily and can now be found throughout the nation in over 100 unique retail stores."

Bullboard Posts

Pro Women’s Hockey League comes to NHL 25 in December